Birhanu Ayelign1, Meseret Workneh1, Meseret Derbew Molla2, Gashaw Dessie2. 1. Department of Immunology and Molecular Biology, School of Biomedical And Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. 2. Department of Biochemistry, School of Medicine, College of Medicine And Health Sciences, University of Gondar, Gondar, Ethiopia.
Abstract
OBJECTIVE: This review aimed to assess the role of vitamin D supplementation on the decrement of mortality and morbidity rate among tuberculosis (TB)/human immune deficiency virus (HIV) co-infected clients.Method: Pub Med, google scholar and google search were accessed to find out all document to describe this review article. RESULTS: Nowadays TB/HIV co-infection has become a major global concern, particularly in low and middle-income countries. Mycobacterium tuberculosis and HIV infections are co-endemic and more susceptible to the progression of TB. Immunosuppression associated with HIV is a strong risk factor for the reactivation of latent TB to the active form. Immune cells like macrophages recognized Mycobacterium tuberculosis through TLR2/1, and it increases the expression of the vitamin D receptor (VDR) and CYP27B1. The synthesis of 1,25-dihydroxy vitamin D promotes VDR-mediated transactivation of the antimicrobial peptide cathelicidin and the killing of intracellular Mycobacterium tuberculosis. Cathelicidins have a direct antimicrobial effect through membrane disruption. Besides, it has also antiviral effects via inhibition of retrovirus (HIV) replication. In fact, as some studies showed, there was a lower induction of cathelicidin in monocytes who have low vitamin D levels. Conclusion: Therefore, vitamin D supplementation can be directly involved in the reduction of TB/HIV co-infection and its progression.
OBJECTIVE: This review aimed to assess the role of vitamin D supplementation on the decrement of mortality and morbidity rate among tuberculosis (TB)/human immune deficiency virus (HIV) co-infected clients.Method: Pub Med, google scholar and google search were accessed to find out all document to describe this review article. RESULTS: Nowadays TB/HIV co-infection has become a major global concern, particularly in low and middle-income countries. Mycobacterium tuberculosis and HIV infections are co-endemic and more susceptible to the progression of TB. Immunosuppression associated with HIV is a strong risk factor for the reactivation of latent TB to the active form. Immune cells like macrophages recognized Mycobacterium tuberculosis through TLR2/1, and it increases the expression of the vitamin D receptor (VDR) and CYP27B1. The synthesis of 1,25-dihydroxy vitamin D promotes VDR-mediated transactivation of the antimicrobial peptide cathelicidin and the killing of intracellular Mycobacterium tuberculosis. Cathelicidins have a direct antimicrobial effect through membrane disruption. Besides, it has also antiviral effects via inhibition of retrovirus (HIV) replication. In fact, as some studies showed, there was a lower induction of cathelicidin in monocytes who have low vitamin D levels. Conclusion: Therefore, vitamin D supplementation can be directly involved in the reduction of TB/HIV co-infection and its progression.
Authors: Amelia C Crampin; J Nimrod Mwaungulu; Frank D Mwaungulu; D Totah Mwafulirwa; Kondwani Munthali; Sian Floyd; Paul Em Fine; Judith R Glynn Journal: AIDS Date: 2010-01-28 Impact factor: 4.177
Authors: Graeme Meintjes; Stephen D Lawn; Fabio Scano; Gary Maartens; Martyn A French; William Worodria; Julian H Elliott; David Murdoch; Robert J Wilkinson; Catherine Seyler; Laurence John; Maarten Schim van der Loeff; Peter Reiss; Lut Lynen; Edward N Janoff; Charles Gilks; Robert Colebunders Journal: Lancet Infect Dis Date: 2008-08 Impact factor: 25.071
Authors: Graeme Meintjes; Katalin Andrea Wilkinson; Molebogeng Xheeda Rangaka; Keira Skolimowska; Kerryn van Veen; Musaed Abrahams; Ronnett Seldon; Dominique J Pepper; Kevin Rebe; Priscilla Mouton; Gilles van Cutsem; Mark Patrick Nicol; Gary Maartens; Robert John Wilkinson Journal: Am J Respir Crit Care Med Date: 2008-08-28 Impact factor: 21.405
Authors: Linda Larcombe; Pamela Orr; Emily Turner-Brannen; Caroline R Slivinski; Peter W Nickerson; Neeloffer Mookherjee Journal: PLoS One Date: 2012-07-16 Impact factor: 3.240
Authors: Jorge B Cannata-Andía; Augusto Díaz-Sottolano; Pehuén Fernández; Manuel Naves-Díaz; Walter Douthat; José L Fernández-Martín; Carmen Palomo-Antequera; Pablo Herrero-Puente; Ricardo Mouzo; Natalia Carrillo-López; Sara Panizo; Guillermo H Ibañez; Carlos A Cusumano; Carolina Ballarino; Vicente Sánchez-Polo; Jacqueline Pefaur-Penna; Irene Maderuelo-Riesco; Jesús Calviño-Varela; Mónica D Gómez; Carlos Gómez-Alonso; John Cunningham Journal: BMC Med Date: 2022-02-18 Impact factor: 8.775
Authors: Rbab Taha; Shahd Abureesh; Shuruq Alghamdi; Rola Y Hassan; Mohamed M Cheikh; Rania A Bagabir; Hani Almoallim; Altaf Abdulkhaliq Journal: Int J Gen Med Date: 2021-07-24